DEFINED DAILY DOSES IN RELATION TO HYPOLIPEMIC EFFICACY OF LOVASTATIN, PRAVASTATIN, AND SIMVASTATIN

被引：82
|
作者：
ILLINGWORTH, DR
ERKELENS, DW
KELLER, U
THOMPSON, GR
TIKKANEN, MJ
机构：
[1] UNIV UTRECHT HOSP, DEPT ENDOCRINOL, UTRECHT, NETHERLANDS
[2] KANTONSSPITAL, DEPT INTERNAL MED, CH-4031 BASEL, SWITZERLAND
[3] HAMMERSMITH HOSP, MRC, LIPOPROT TEAM, LONDON W12 0HS, ENGLAND
[4] UNIV HELSINKI HOSP, DEPT INTERNAL MED, HELSINKI, FINLAND
来源：
LANCET | 1994年 / 343卷 / 8912期
关键词：
D O I：
10.1016/S0140-6736(94)92945-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1554 / 1555
页数：2
相关论文
共 50 条
  • [21] COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA
    DAUBRESSE, JC
    DEBACKER, G
    DUCOBU, J
    HARVENGT, C
    DEGENNES, JL
    DOUSTEBLAZY, P
    FARNIER, M
    ANDERS, G
    DAMMANN, HG
    NEUMANN, E
    SCHWARZE, B
    SEIFART, C
    KASTELEIN, J
    STALENHOEF, A
    KEIDAR, S
    CAPURSO, A
    DECESARIS, R
    DESCOVICH, G
    FELLIN, R
    FERUGLIO, F
    MALINI, P
    TRIMARCO, B
    SCOTT, R
    MARAIS, A
    KELLER, U
    MOCCETTI, T
    BLOOMFIELD, P
    CRAMB, R
    HUGHES, E
    SEED, M
    WRAY, R
    STEIN, E
    FRUCHART, J
    SWEANY, A
    SHAPIRO, D
    TATE, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (16): : 1408 - 1414
  • [22] Effectiveness of atorvastatin in treating patients to LDL-C goals compared with lovastatin, pravastatin and simvastatin
    Nawrocki, J
    Shurzinske, L
    Black, DM
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 120 - 120
  • [23] SIMVASTATIN VERSUS PRAVASTATIN - EFFICACY AND TOLERABILITY IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
    MALINI, PL
    AMBROSIONI, E
    DEDIVITIIS, O
    DISOMMA, S
    ROSIELLO, G
    TRIMARCO, B
    CLINICAL THERAPEUTICS, 1991, 13 (04) : 500 - 510
  • [24] Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin
    Weir, MR
    Berger, ML
    Weeks, ML
    Liss, CL
    Santanello, NC
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (07): : 475 - 479
  • [25] Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation
    Keogh, A
    Macdonald, P
    Kaan, A
    Aboyoun, C
    Spratt, P
    Mundy, J
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (06): : 529 - 537
  • [26] Effects of equal doses of Pravastatin, Simvastatin and Atorvastatin in heterozygous patients with familial Hypercholestrolemia
    De Mattei, S
    Masturzo, P
    Fascetti, V
    Elicio, N
    Bertolini, S
    ATHEROSCLEROSIS, 1999, 145 : S24 - S24
  • [27] dANTIFUNGAL ACTIVITY IN VITRO OF STATINS: A COMPARATIVE STUDY OF SIMVASTATIN, FLUVASTATIN, LOVASTATIN, PRAVASTATIN AND ATORVASTATIN AGAINST CANDIDA
    Gil-Alonso, S.
    Santano, D.
    Quindos, G.
    Eraso, E.
    Ortega, I
    Jauregizar, N.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 60 - 60
  • [28] Comparative dose efficacy study of Atorvastatin versus Simvastatin, pravastatin, Lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES study) (vol 81, pg 582, 1998)
    Jones, P
    Kafonek, S
    Laurora, I
    Hunninghake, D
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (01): : 128 - 128
  • [29] Simvastatin in management of patients with primary hypercholesterolemia: Tolerability and efficacy of daily doses 10-80 mg
    Susekov, AV
    Solovyeva, EY
    Rozhkova, TA
    Kotova, LA
    Akhmedova, ZA
    Kukharchuk, VV
    KARDIOLOGIYA, 2002, 42 (01) : 33 - 36
  • [30] Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy
    Hersi, Hire
    Raitanen, Jani
    Saarinen, Jukka T.
    Peltola, Jukka
    EPILEPSIA OPEN, 2023, 8 (03) : 811 - 819
12345